Browse EX-10 agreements

CERTAIN INFORMATION, IDENTIFIED BY AND REPLACED WITH A MARK OF “[ ],” HAS BEEN EXCLUDED FROM THIS DOCUMENT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

| | | | | | |

…

NOTICE OF DIRECTOR RESTRICTED SHARE UNIT AWARD

UNDER THE APOLLO GLOBAL MANAGEMENT, INC.
2019 OMNIBUS EQUITY INCENTIVE PLAN

Apollo Global Management, Inc. (the “Company”), pursuant to the Apollo Global Management, Inc. 2019 Omnibus Equity Incentive Plan (as amended from time to time, the “Plan”), hereby grants to the individual listed below the number of Restricted Share Units (the “RSUs”) set forth below. The RSUs are subject to the terms and conditions as set forth in this Notice of Restricted Share Unit Award (the “Notice”), the attached Award Agreement (the “Award Agreement”) and the Plan.

…

Silence Therapeutics Plc

221 River Street, 9th Floor

Hoboken, NJ 07030

July 9, 2026

Craig Tooman

*********

*******

Mr. Tooman:

This letter sets forth the substance of the separation and release agreement (the “Agreement”) that Silence Therapeutics Plc (the “Company”) is offering to you to aid in your employment transition. You and the Company are referred to individually as a “Party” and together as the “Parties”.

1.Separation.Your last day of work with the Company and your employment termination date was December 14, 2025 (the “Separation Date”).

2.Final Pay.You have been paid all accrued salary and will be paid for all accrued and unused vacation earned through the Separation Date on the next regular payroll date following the Separation Date, subject to standard payroll deductions and withholdings. You are entitled to these payments by law.

…

JADE BIOSCIENCES, INC.

2026 EMPLOYMENT INDUCEMENT STOCK INCENTIVE PLAN

GRANT NOTICE FOR
STOCK OPTIONS

FOR GOOD AND VALUABLE CONSIDERATION, Jade Biosciences, Inc. (the “Company”), hereby grants to Participant named below an option (the “Option”) to purchase any part or all of the number of shares of Common Stock that are covered by this Option at the Exercise Price per share, each specified below, and upon the terms and subject to the conditions set forth in this Grant Notice, the Jade Biosciences, Inc. 2026 Employment Inducement Stock Incentive Plan (as amended from time to time, the “Plan”), and the Standard Terms and Conditions, including any country-specific provisions attached thereto (the “Standard Terms and Conditions”) promulgated under such Plan and attached hereto as Exhibit A. This Option is granted pursuant to the Plan and is subject to and qualified in its entirety by the Standard Terms and Conditions. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan.

…

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Confidential

Execution Version

LICENSE AGREEMENT

This License Agreement(“Agreement”) is entered into and effective as of June 29, 2026 (the “Effective Date”), by and between Paragon Therapeutics, Inc., a Delaware corporation (“Paragon”), and Jade Biosciences, Inc., a Nevada corporation (“Jade”). Paragon and Jade are also referred to herein individually as a “Party,” or collectively as the “Parties.”

Recitals

Whereas,Paragon has developed a proprietary platform technology for the discovery and development of antibodies against therapeutically relevant targets;

…

Director Form

JADE BIOSCIENCES, INC.

2025 STOCK INCENTIVE PLAN

GRANT NOTICE FOR
STOCK OPTIONS

FOR GOOD AND VALUABLE CONSIDERATION, Jade Biosciences, Inc. (the “Company”), hereby grants to Participant named below an option (the “Option”) to purchase any part or all of the number of shares of Common Stock that are covered by this Option at the Exercise Price per share, each specified below, and upon the terms and subject to the conditions set forth in this Grant Notice, the Jade Biosciences, Inc. 2025 Stock Incentive Plan (as amended from time to time, the “Plan”), and the Standard Terms and Conditions (the “Standard Terms and Conditions”) promulgated under such Plan and attached hereto as Exhibit A. This Option is granted pursuant to the Plan and is subject to and qualified in its entirety by the Standard Terms and Conditions. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan.

| |

Employee Form

JADE BIOSCIENCES, INC.

2025 STOCK INCENTIVE PLAN

GRANT NOTICE FOR
STOCK OPTIONS

FOR GOOD AND VALUABLE CONSIDERATION, Jade Biosciences, Inc. (the “Company”), hereby grants to Participant named below an option (the “Option”) to purchase any part or all of the number of shares of Common Stock that are covered by this Option at the Exercise Price per share, each specified below, and upon the terms and subject to the conditions set forth in this Grant Notice, the Jade Biosciences, Inc. 2025 Stock Incentive Plan (as amended from time to time, the “Plan”), and the Standard Terms and Conditions, including any country-specific provisions attached thereto (the “Standard Terms and Conditions”) promulgated under such Plan and attached hereto as Exhibit A. This Option is granted pursuant to the Plan and is subject to and qualified in its entirety by the Standard Terms and Conditions. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan.

…

Execution Version THIRD AMENDMENT TO CREDIT AGREEMENT This THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of June 16, 2026, by and among N-able International Holdings II, LLC, a Delaware limited liability company (the “Borrower”), N-able International Holdings I, LLC, a Delaware limited liability company (“Holdings”), JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”) and each 2026 Incremental DDTL Lender (as defined below), and, solely with respect to the representations and warranties in Section 7 and the acknowledgements set forth in Section 8 and Section 11(d) hereof, the other Guarantors party hereto. W I T N E S S E T H: WHEREAS, the Borrower, Holdings, the lenders party thereto, the Administrative Agent and the Collateral Agent, among others, are party to that certain Credit Agreement, dated as of July 19, 2021 (as amended by that certain First Amendment to Credit Agreement, dated as of June 26, 2023, that certain Second Amendment to Credit Agreement, dated as of November 26, 2025, and as further amended, restate

…

SECOND AMENDMENT TO

RESTRICTED STOCK AWARD AGREEMENT

Freedom Holding Corp. 2019 Equity Incentive Plan

This Second Amendment to Restricted Stock Award Agreement (this “Second Amendment”) is made and entered into as of July 16, 2026, by and between:

(1) Freedom Holding Corp., a Nevada corporation (the “Company”),

and

(2) Alexey Lee(the “Grantee”),

collectively referred to as the “Parties”.

RECITALS;

WHEREAS, the Company and the Grantee entered into a Restricted Stock Award Agreement dated May 29, 2025 (the “Original Agreement”), pursuant to which the Grantee was granted a total of 72,700 shares of the Company’s common stock vesting in four equal annual tranches of 18,175 shares of the Company’s common stock each over a four-year period;

WHEREAS, the Parties previously entered into an Amendment to the Original Agreement dated January 19, 2026 (the “First Amendment”), which revised the initial vesting date under the Original Agreement to August 25, 2026;

…

Certain portions of this exhibit (indicated by “[***]”) have been omitted pursuant to Item 601(a)(6) of Regulation S-K.

This exhibit is an English translation of a foreign language document. The Company hereby agrees to furnish to the SEC, upon request, a copy of the foreign language document.

EMPLOYMENT AGREEMENT No. 25-376

city of Almaty                                        July 1, 2025

Freedom Holding Operations Limited Liability Partnership, established in accordance with the legislation of the Republic of Kazakhstan, BIN 240340008470, located at: Republic of Kazakhstan, Almaty, Bostandyk District, Al-Farabi Avenue, 77/7, Building 3A, postal code 050040, represented by Mynbayev Ablai Bolatuly, Finance Director of the Finance Management Department, acting on the basis of Power of Attorney No. 12/17 dated December 17, 2024 (hereinafter the "Employer" or the "Company"), on the one part, and

Full name: Shotbaev Marat Alibekovich

Citizenship: Kazakhstan

Registered address / registration address: [***]

Actual place of residence: [***]

…

FREEDOM US MARKETS

June 22, 2026

Dear Alexey,

We are thrilled to extend to you a full-time offer as Executive Director of the Product Management Departmentat Freedom US Markets. We are confident that your experience and expertise will make a significant contribution to our team and we look forward to welcoming you on board.

Duties; Schedule; Place of Work

In this role, you will report directly to Timur Turlov. You will be a full-time employee scheduled to work five days a week.

As this is a fully remote position, you will perform your duties from your home office or other approved remote work location in the State of California. The Company reserves the right to require your attendance at the Company's offices for meetings, training, or other business purposes upon reasonable advance notice. Any changes to your remote work arrangement will be communicated to you in writing.

Compensation

Your annual salary will be the gross amount of $365,000 (Three Hundred Sixty-Five Thousand Dollars per year), less withholdings for taxes and such other deductions required by law.

…

Restricted Stock Award Agreement

Freedom Holding Corp. 2019 Equity Incentive Plan

This Restricted Stock Award Agreement (this "Agreement") is made and entered into as of May 29, 2026, (the "Grant Date") by and between Freedom Holding Corp., a Nevada corporation (the "Company") and Azamat Yerdessov (the "Grantee").

WHEREAS, the Company has adopted the Freedom Holding Corp. 2019 Equity Incentive Plan (as may be amended from time to time, the "Plan") pursuant to which awards of Restricted Stock may be granted; and

WHEREAS, the Committee has determined that it is in the best interests of the Company and its shareholders to grant the award of Restricted Stock provided for herein.

NOW, THEREFORE, the parties hereto, intending to be legally bound, agree as follows:

…